Quality and Outcome Measurements of Urological Patients

Recruiting

• Conditions: Urologic Diseases

• Registration Number: NCT04763538
• Lead Sponsor: Insel Gruppe AG, University Hospital Bern

Brief Summary

Prospectively, all available parameters of urologic patients treated at the study sites will be acquired and stored in multilayered databases. Upon a given samples size, neuronal networks will be trained to define clinical endpoints. Beside uro-oncological patients also patients with other urological diseases will be enrolled.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2021-02-16
• Study First Submitted QC: 2021-02-16
• Study First Posted: 2021-02-21
• Study Start: 2021-09-01
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-09
• Last Update Posted: 2023-03-10
• Primary Completion: 2026-04-30
• Study Completion: 2028-04-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• All patients treated at the study sites, signed informed consent

Exclusion Criteria

• No consent to record medical history

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease specific primary endpoint	4-5 years	Neuronal networks will be trained to define the respective endpoints for the diseases

Trial Locations

Locations (2)

Roland Seiler; 🇨🇭 Biel, Switzerland

Department of Urology, Hospital Center Biel; 🇨🇭 Biel, Switzerland